Notice of Correction of Key Dates for RFA-HL-26-012 "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
Notice Number:
NOT-HL-25-031

Key Dates

Release Date:

September 12, 2025

Related Announcements

  • August 26, 2025 - Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed). See NOFO RFA-HL-26-012.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to alert potential applicants to changes in key dates for RFA-HL-26-012 "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)". Changes are shown in bold italics below.

Original dates:

Part 1. Overview Information

Key Dates

Posted Date
August 26, 2025

Open Date (Earliest Submission Date)
September 14, 2026

Letter of Intent Due Date(s)
Not Applicable

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
October 14, 2026October 14, 2026January 08, 2026March 2026May 2026July 2026
October 13, 2027October 13, 2027January 08, 2027March 2027May 2027July 2027
October 13, 2028October 13, 2028January 10, 2028March 2028May 2028July 2028

All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date
January 11, 2028

Revised dates (in bold italics):

Part 1. Overview Information

Key Dates

Posted Date
August 26, 2025

Open Date (Earliest Submission Date)
September 14, 2025

Letter of Intent Due Date(s)
Not Applicable

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
October 14, 2025October 14, 2025January 08, 2026March 2026May 2026July 2026
October 13, 2026October 13, 2026January 08, 2027March 2027May 2027July 2027
October 13, 2027October 13, 2027January 10, 2028March 2028May 2028July 2028

All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date
January 11, 2028

All other aspects of RFA-HL-26-012 remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

David Schopfer, M.D.
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-402-3833
Email: [email protected]